Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT02108535Phase 4Completed

Comparative Analysis of Cost-effectiveness of Silver Dressing in Burns

Role: lead

NCT04186780Not ApplicableCompleted

Effects of Lentinula Edodes Bars on Dyslipidemia and Oxidative Stress in Cholesterol Individuals: Randomized Study

Role: lead

NCT03101020Not ApplicableCompleted

Visceral Manipulation in Patients With Chronic Low Back Pain

Role: lead

NCT03196336Not ApplicableCompleted

Effectiveness of Pharmacotherapy Follow-up Care in Outpatients With Type 2 Diabetes Mellitus

Role: lead

NCT03148223Not ApplicableCompleted

Auriculotherapy in the Treatment of Dysmenorrhea

Role: lead

NCT03031977Not ApplicableCompleted

Visceral Mobilization and Functional Constipation in Stroke Survivors

Role: lead

All 6 trials loaded